6CM
SLS icon

683 Capital Management’s SELLAS Life Sciences SLS Stock Holding History

683 Capital Management’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-66,000
Closed -$400K – 190
2019
Q3 		$400K Sell
66,000
-6,500
-9% -$47.9K 0.07% 101
2019
Q2 		$408K Buy
72,500
+47,000
+184% +$1.67M 0.05% 117
2019
Q1 		$1.3M Sell
25,500
-12,500
-33% -$869K 0.17% 88
2018
Q4 		$2.34M Buy
38,000
+12,500
+49% +$968K 0.35% 84
2018
Q3 		$1.56M Buy
+25,500
New +$1.76M 0.19% 89

Other funds holding SLS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LI
Leap Investments Chicago, Illinois $152M AUM 3.6% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return